Self-developed drugs

Zai Lab licenses other companies’ drugs for commercialization in China.

FAST NEWS: Zai Lab’s loss narrows on improved drug sales

The Latest: Biotech company Zai Lab Ltd. (9688.HK; ZLAB.US) reported Wednesday that its loss narrowed 33.7% to $80.3 million in the second quarter of this year. Looking Up: The company's net product revenue for…
9688.HK ZLAB.US

Recent Articles

RELATED ARTICLES

  1. Biotech company Zai Lab reported Wednesday that its loss narrowed 24.5% to $335 million last year.
    FAST NEWS: Zai Lab’s loss narrows on strengthening sales
    9688.HK ZLAB.US
  2. FAST NEWS: Zai Lab’s loss narrows on growing revenue
    ZLAB.US 9688.HK
  3. CSPC Pharma weighs up diet drug for bigger bottom line
    1093.HK
  4. Everest reaches new heights on growing drug sales
    1952.HK
  5. AstraZeneca pays hefty price for Chinese weight-loss drug
    AZN.US
  6. BeiGene’s aggressive expansion brings revenue jolt
    BGNE.US 6160.HK 688235.SHG
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva